EOG
49
4
UPS
51
-2
KIM
51
4
AAP
27
3
ABBV
64
4
GIS
58
-2
GS
69
-3
AIV
62
-2
CMA
52
2
CVX
25
2
TSCO
55
2
TGNA
66
2
SNA
60
2
NKE
39
2
HCP
49
-3
BWA
61
-7
JPM
71
2
MMC
70
2
HAL
50
4
ORCL
68
3
EOG
49
4
UPS
51
-2
KIM
51
4
AAP
27
3
ABBV
64
4
GIS
58
-2
GS
69
-3
AIV
62
-2
CMA
52
2
CVX
25
2
TSCO
55
2
TGNA
66
2
SNA
60
2
NKE
39
2
HCP
49
-3
BWA
61
-7
JPM
71
2
MMC
70
2
HAL
50
4
ORCL
68
3
Financhill
Back

OptimizeRx 10K Form

Buy
56

OPRX
OptimizeRx

Last Price:
12.72
Seasonality Move:
11.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-05 10Q OPRX/OptimizeRx Quarterly
2020-05-06 10Q OPRX/OptimizeRx Quarterly
2020-03-26 10K OPRX/OptimizeRx Annual
2019-11-05 10Q OPRX/OptimizeRx Quarterly
2019-08-07 10Q OPRX/OptimizeRx Quarterly
2019-05-08 10Q OPRX/OptimizeRx Quarterly

Receive OPRX News And Ratings

See the #1 stock for the next 7 days that we like better than OPRX

OPRX Financial Statistics

Sales & Book Value

Annual Sales: $71.52M
Cash Flow: $1.97M
Price / Cash Flow: 0
Annual Sales: $6.74
Price / Book: 1.89

Profitability

EPS (TTM): -1.03000
Net Income (TTM): $-18.07M
Gross Margin: $42.9M
Return on Equity: -14.93%
Return on Assets: -12.26%

OptimizeRx Earnings Forecast

Key OptimizeRx Financial Ratios

  • The Gross Profit Margin over the past 17 years for OPRX is 59.98%.
  • The Selling, General & Administrative Expenses for OPRX have been equal to 81.12% of Gross Profit Margin.
  • The Research & Development expenses have been 2.49% of Revenue.
  • The Interest Expense is -8.28% of Operating Income.
  • The Net Earning history of OPRX is -24.56% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 7 years.

OptimizeRx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: OPRX
CUSIP: 68401U
Website: optimizerx.com

Debt

Debt-to-Equity Ratio: 0.29
Current Ratio: 2.88
Quick Ratio: 2.74

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 24.14

OPRX Technical Analysis vs Fundamental Analysis

Buy
56
OptimizeRx (OPRX) is a Buy

Is OptimizeRx a Buy or a Sell?

  • OptimizeRx stock is rated a Buy
    The current OptimizeRx [OPRX] share price is $12.69. The Score for OPRX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.